- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Gland Pharma Ltd (GLAD)
Gland Pharma Ltd stock price live, this page displays NSE GLAD stock exchange data. View the GLAD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Gland Pharma Ltd real time stock price chart below.
What Is the Gland Pharma Ltd Stock Price Today?
The Gland Pharma Ltd stock price today is 1,927.50.
What Is the Stock Symbol for Gland Pharma Ltd?
The stock symbol for Gland Pharma Ltd is ""GLAD.""
What Stock Exchange Does Gland Pharma Ltd Trade On?
Gland Pharma Ltd is listed and trades on the NSE stock exchange.
Is Gland Pharma Ltd a Good Stock to Buy?
Determining whether Gland Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GLAD quote. (ISIN: INE068V01023)
What Is the Gland Pharma Ltd Stock Price Today?
The Gland Pharma Ltd stock price today is 1,927.50.
What Is the Stock Symbol for Gland Pharma Ltd?
The stock symbol for Gland Pharma Ltd is ""GLAD.""
What Stock Exchange Does Gland Pharma Ltd Trade On?
Gland Pharma Ltd is listed and trades on the NSE stock exchange.
Is Gland Pharma Ltd a Good Stock to Buy?
Determining whether Gland Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GLAD quote. (ISIN: INE068V01023)
1,927.50
-13.50(-0.70%)
Closed·
Fair Value
An estimate of a Gland's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,913.10
1,947.40
52 wk Range
1,277.80
2,131.00
GLAD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
GLAD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Gland's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,913.101,947.40
52 wk Range
1,277.802,131.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GLAD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Gland's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
1,862.83
Downside
-3.35%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
- Grand Canal receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Gland Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Grand Canal receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Gland Pharma Ltd Company Profile
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro-intestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain/analgesics, respiratory and pulmonology, and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier compilation, technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Compare GLAD to Peers and Sector
Metrics to compare | GLAD | Peers Peers - average of corresponding metrics from companies closely matching GLAD: AJANTPHARM, APLLTD, JUBLPHARMA, COHANCE, STAR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGLADPeersSector |
|---|---|---|---|---|
P/E Ratio | 41.5x | 31.0x | −0.6x | |
PEG Ratio | 6.26 | 0.02 | 0.00 | |
Price/Book | 3.5x | 5.1x | 2.6x | |
Price / LTM Sales | 5.6x | 3.9x | 3.3x | |
Upside (Analyst Target) | −2.9% | 19.8% | 39.0% | |
Fair Value Upside | Unlock | 0.4% | 4.9% | Unlock |
Analyst Ratings
5 Buy
2 Hold
5 Sell
Ratings:
12 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 1,862.83
(-3.35% Downside)
Earnings
Latest Release
Aug 05, 2025
EPS / Forecast
13.08 / 12.97
Revenue / Forecast
15.06B / 15.30B
People Also Watch
FAQ
What Stock Exchange Does Gland Trade On?
Gland is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Gland?
The stock symbol for Gland is "GLAD."
What Is the Gland Market Cap?
As of today, Gland market cap is 325.53B.
What Is Gland's Earnings Per Share (TTM)?
The Gland EPS (TTM) is 46.75.
When Is the Next Gland Earnings Date?
Gland will release its next earnings report on 09 Nov 2025.
From a Technical Analysis Perspective, Is GLAD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Gland Stock Split?
Gland has split 0 times.
How Many Employees Does Gland Have?
Gland has 4351 employees.
What is the current trading status of Gland (GLAD)?
As of 26 Aug 2025, Gland (GLAD) is trading at a price of 1,927.50, with a previous close of 1,941.00. The stock has fluctuated within a day range of 1,913.10 to 1,947.40, while its 52-week range spans from 1,277.80 to 2,131.00.
What Is Gland (GLAD) Price Target According to Analysts?
The average 12-month price target for Gland is INR1862.83333, with a high estimate of INR2340 and a low estimate of INR1084. 5 analysts recommend buying the stock, while 5 suggest selling, leading to an overall rating of Neutral. The stock has an -3.35% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.